Securities code: 300006 securities abbreviation: Chongqing Lummy Pharmaceutical Co.Ltd(300006) Announcement No.: 2021-084 Chongqing Lummy Pharmaceutical Co.Ltd(300006)
Announcement on the addition of non independent directors by the company
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Chongqing Lummy Pharmaceutical Co.Ltd(300006) (hereinafter referred to as “the company”) was posted on cninfo.com on December 11, 2021（ http://www.cn.info.com..cn. ）The announcement on the resignation of non independent directors of the company (Announcement No.: 2021-081) was disclosed. Ms. Chen Xiaohui applied for resignation from the position of non independent director and member of the strategy committee under the board of directors for personal reasons, and no longer held any position in the company after resignation. In order to ensure the normal operation of the board of directors of the company, in accordance with the company law of the people’s Republic of China and the articles of association In combination with the nomination committee of the board of directors and the Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) nomination of the controlling shareholder, the proposal on nominating Mr. Liang Jiansheng as a candidate for non independent director of the Fifth Board of directors was considered and adopted at the 20th meeting of the Fifth Board of directors of the company, Agree to nominate Mr. Liang Jiansheng (see the appendix for resume) as the candidate for non independent director of the 5th board of directors of the company, and the term of office starts from the date of deliberation and approval by the general meeting of shareholders of the company to the expiration of the term of office of the 5th board of directors. The independent directors of the company expressed their independent opinions on the qualification and nomination procedures of Mr. Liang Jiansheng’s candidate for non independent director.
After the completion of the above additional directors, the total number of directors concurrently serving as senior managers and employees’ representatives among the members of the Fifth Board of directors of the company does not exceed half of the total number of directors of the company, meeting the requirements of relevant laws and regulations. This addition of directors needs to be submitted to the second extraordinary general meeting of shareholders of the company in 2021 for deliberation.
It is hereby announced.
Chongqing Lummy Pharmaceutical Co.Ltd(300006) appendix of the board of directors on December 14, 2021: resume of candidates for non independent directors of the Fifth Board of directors of the company
Resume of candidates for non independent directors of the 5th board of directors of the company
Mr. Liang Jiansheng, born in October 1982, Chinese nationality, without overseas residency, graduate degree, political engineer and member of the Communist Party of China. Started work in July 2006, He used to be the party business manager of the human resources department (Party Committee Office) of Guangxi Investment Group Co., Ltd.; he was appointed Deputy Manager of the human resources department and deputy director of the Party Committee Office of Guangxi longxianggu Investment Co., Ltd.; Deputy Manager of the human resources department and deputy director of the Party Committee Office of Guangxi longxianggu Investment Co., Ltd (presiding over the work); Deputy General Manager of general management department of Guangxi Investment Group Financial Holding Co., Ltd. (presiding over the work); Deputy General Manager of party masses work department of Guangxi Investment Group Co., Ltd. (deputy director of trade union office); Deputy General Manager of party masses work department / trade Union Office of Guangxi Investment Group Co., Ltd.; now Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) Deputy Secretary of the Party committee, director, chairman of the trade union and chairman of Guangxi Zhongheng traditional Chinese Medicine Industry Development Co., Ltd.
Up to now, Mr. Liang Jiansheng does not hold any shares in the company. He and the current non independent directors Mr. Peng Weimin, Mr. Ou Rihua, Mr. Hu Leibing and Ms. Tang Weiyan are appointed by the controlling shareholder of the company Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) and hold relevant positions in Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) or its subsidiaries. In addition to the above relationship, he has no relationship with other shareholders holding more than 5% shares of the company, Having the qualification to serve as a director of a listed company, there are no conditions prohibited by the company law and the articles of association and the punishment of being banned from entering the securities market by the CSRC, and there is no article 3.2 of the guidelines for the standardized operation of companies listed on the gem of Shenzhen Stock exchange Under the circumstances specified in Article 4, the person subjected to execution is not dishonest.
